Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Arch Biopartners Inc V.ARCH

Alternate Symbol(s):  ACHFF

Arch Biopartners Inc. is a late-stage clinical trial company focused on preventing acute kidney injury. The Company is developing a platform of new drugs to prevent inflammation injury in the kidneys, lungs and liver via the dipeptidase-1 (DPEP1) pathway and are relevant for many common injuries and diseases where organ inflammation is an unmet problem. The Company’s lead drug candidate is... see more

TSXV:ARCH - Post Discussion

Arch Biopartners Inc > Bring in the cavalry
View:
Post by stocksarefun on Dec 06, 2021 10:28am

Bring in the cavalry

The volume will come soon, and these games we're seeing every day won't be possible for much longer.

US Institutions are licking their lips right now waiting.
Comment by GoldenArm on Dec 06, 2021 11:04am
Yup seeing manipulation in a lot of stocks. Big reversal of the markets as well today whoever it is still early. I doubled up and got worried  when it went down but held on. I was playing with house money but not anymore. The press and the results should propel this stock forward. Key things to watch for is how long this study will take, how fast will the results be collated and presented ...more  
Comment by Riverfolk on Dec 06, 2021 12:20pm
One of the main reasons that clinical trials take a tremendous amount of time (3.5 years) is that the quality of drug is increased as the drug moves from Phase I-Phase II-Phase III (10.5 years). This process can take up to 9 months in preparation for the next trial. Often retail does not understand this as the process is not common as with 85% phase II failure rate. Comparing the normal process of ...more  
Comment by Riverfolk on Dec 06, 2021 12:27pm
It’s been a quicker process than usual to get Metablok to this point, said Muruve, a timeline that’s been condensed due to a research focus on identifying treatments that can reduce mortality from COVID-19. “There’s a good chance that by 2022 we’ll know for sure how effective our drug is,” he said. “We saw it with the vaccines, and there’s a number of other drugs that have been accelerated ...more  
Comment by fourbarrels on Dec 06, 2021 12:56pm
I was curious about the "by 2022" statement. Does that mean he figures by the end of this year (in next 3 weeks)? Or sometime in 2022? What is your take Riverfolk?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities